Phase I Study Evaluating Kin-3248, A Next-Generation, Irreversible Pan-Fgfr Inhibitor, In Patients With Advanced Cholangiocarcinoma, Urothelial Carcinoma And Other Solid Tumors Harboring Fgfr2 And/Or Fgfr3 Gene Alterations
KIN-3248
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I Study Evaluating Kin-3248, A Next-Generation, Irreversible Pan-Fgfr Inhibitor, In Patients With Advanced Cholangiocarcinoma, Urothelial Carcinoma And Other Solid Tumors Harboring Fgfr2 And/Or Fgfr3 Gene Alterations ### Output: KIN-3248